Skip to main content
. 2015 Nov 2;7(13):15507–15524. doi: 10.18632/oncotarget.6266

Figure 7. Vessel staining in human renal unsorted RCC-41-PDX-2 and RCC-41-PDX-2 cell subsets subcutaneously injected in SCID mice.

Figure 7

(A) Representative hematoxylin/eosin and immunofluorescence stainings of serial tumor sections showing positivity for mouse CD34 but not for human CD31 antibodies in RCC-41/PDX-2-derived xenografts. (B) Representative immunofluorescence stainings of serial tumor sections showing positivity for mouse CD34 and human CD146 antibodies in RCC-41/PDX-2 subsets.